INTRODUCTION
Isolated calf vein thrombosis (CVT) is comprised of muscular (soleal and gastrocnemius sinus) and deep (posterior tibial, anterior tibial, and peroneal veins) venous thrombosis (DVT) in the calf. Unlike proximal DVT, the clinical importance of CVT has often been underestimated. CVTs are more frequently detected and its clinical significance has been discussed since ultrasonography (US) was first used for the diagnosis of DVT [1, 2] . The prevalence of CVT is 5 to 12% in patients with symptomatic venous thrombosis [3] . CVT may develop in 15% of asymptomatic patients after hip and knee surgery, and in 45% of patients after coronary bypass grafting [4] [5] [6] .
For the treatment of CVT, international guidelines recommend three months of oral anticoagulation therapy at the full therapeutic dosage [7] . However, in clinical practice, we have encountered frequent resolution of CVT after short-duration anticoagulation therapy, as well as cases of spontaneous resolution. Therefore, questions have been raised regarding the optimal duration of anticoagulation for patients with CVT and risk factors for delayed recanalization after anticoagulation.
The purposes of this study were to observe recanalization rates in CVT patients at 1 and 3 months, and to determine the risk factors related to delayed recanalization of CVT. Values are presented as number (%) or mean ± SD. Values are presented as number (%). 
METHODS

RESULTS
During the study period, data for 292 limbs with iso- A comparison of patient demographics and coexisting risk factors for VTE between patients who received anticoagulation and those who did not is shown in Table 1 .
There were no significant differences in the frequencies of risk factors between the two groups except for cases in which the patient had a history of recent surgery, which were more common in anticoagulation group than in the no anticoagulation group (94% vs. 74.4%, P = 0.003). The most common coexisting risk factor for DVT was recent surgery, which occurred in 95 patients (86.4%), of which orthopedic surgery (knee or hip replacement arthroplasty) was the most prevalent (77 patients, 70%).
The distributions of CVT and symptoms/signs are shown in .7) with CVT on duplex US. As shown in Fig. 1 , according to Kaplan-Meier estimates, the recanalization rate of CVT was significantly higher in the oral anticoagulation group than in the no oral anticoagulation group (84% vs.
64.8%, P = 0.008) (Fig. 1) . However, no significant difference was detected in the recanalization rate between muscular CVT and deep CVT (81% vs. 85%, P = 0.564).
According to our univariate risk factor analysis for recanalization of CVT, immobilization, coexisting cancer, recent surgery, and anticoagulation therapy significantly influenced the recanalization of CVT (Table 3 ). Multivariate analysis revealed that immobilization (P = 0.029; OR, 4.191) and coexisting cancer (P = 0.043; OR, 2.789) were independent risk factors associated with delayed recanalization of CVT, whereas anticoagulation therapy (P = 0.020; OR, 0.300) was likely to promote the recanalization of CVT (Table 4) .
Among 110 CVT patients, progression to proximal DVT and PE was detected in 1 (0.9%) of limbs and 6 (5.5%) of patients, respectively. During the follow-up period, three patients (2.7%) died of cancer or gastrointestinal bleeding, however there was no recurrence of CVT or PE during the follow-up period.
DISCUSSION
Isolated CVT is a common finding but was often ignored until US was used for the diagnosis of venous thrombosis. Incidence of CVT is known to be 100 times higher than that of symptomatic DVT [8, 9] . It is assumed that most of these small thrombi resolve completely via natural mechanisms of thrombolysis, although some of thesurgery.or.kr them progress to symptomatic or proximal DVT [10] . The clinical importance of CVT arises from its potential risk of progression to the proximal vein and risk of PE. Some cases of CVT have been known to progress into the deep veins as well as to symptomatic PE [11, 12] . MacDonald et al. [13] reported on the progression rate of isolated CVT to the level of adjacent tibial or peroneal veins or higher in 22 (16.3%) of the 135 limbs studied and 4 (3%) extensions to the popliteal vein during a 3-month follow-up in a cohort followed by duplex US without any treatment. Schwarz et al. [12] conducted a prospective nonrandomized study including 84 isolated muscular CVTs and showed a significantly higher rate of progression to the deep calf veins (25%) in the 32 patients (38 %) who had not undergone anticoagulation therapy [12] . These two studies showed that the proximal extension or progression rates of CVT were higher in patients who were not treated with anticoagulation therapy, and the extension occurred early after the diagnosis in most of the patients. Gillet et al. [14] reported no extension or recurrence rates of CVT at 3 months, but a high (18.8%) rate of VTE recurrence in symptomatic CVT patients in a midterm follow-up (mean, 26.7 months) [14] . In the present study, we observed very low rate (0.9%) of CVT progression to the deep (tibial)
vein, and no patient showed recurrent VTE or symptomatic PE during the follow-up period. Previous research regarding the relationship between CVT and PE has proven equivocal. Although Gillet et al. [14] reported on the development of PE in 7% of cases of isolated CVT, others reported 13 to 15% fatal PE in patients with asymptomatic isolated CVT after surgery [15] . Spontaneous resolution of CVT is known to occur, with a 50% reduction of signs and symptoms at one month and complete resolution of symptom or signs by one year in most patients [16] . However, post-thrombotic manifestations develop in 4% of patients, and valvular incompetence occurs in 20 to 24% of patients [17] . MacDonald et al. [13] reported that complete recanalization of the calf vein at 1 and 3 months occurred in 20.7%
and 44.6% of cases of muscular CVT, respectively. In our study, overall recanalization rates at 1 and 3 months were 23% and 82%, respectively. There was a significant difference in the recanalization rates between the anticoagulation group and the no anticoagulation group (84% vs. There were no known risk factors associated with delayed recanalization of CVT. In the present study, we found that coexisting cancer or immobilization had significantly lower recanalization rates, and longer anticoagulation therapy is required for such patients.
This study has limitations including study design that
was not randomized and therefore may suffer from selection bias. Second, the maximum 3-month follow-up interval is not sufficient to observe the long-term complications of CVT or recurrence of venous thrombosis. Third, we could not check consistently the hypercoagulability state of the patients like as protein C or S and don't have enough data to analyze because most of the patients were in other department like as orthopedic surgery.
In conclusion, for patients with isolated CVT, no oral anticoagulation resulted in a higher rate of delayed recanalization compared with oral anticoagulation therapy. Risk factors associated with delayed recanalization of the calf veins were coexisting cancer and recent long-term immobilization, and CVT in patients with such risk factors are more likely to require longer anticoagulation than in patients with other risk factors.
